FDAnews
www.fdanews.com/articles/108736-insmed-provides-update-on-muscular-dystrophy-programs

Insmed Provides Update on Muscular Dystrophy Programs

July 21, 2008
Insmed’s Phase 2 trial of IPLEX in Myotonic Muscular Dystrophy (MMD), which was initiated in December 2007, has seen a strong patient and physician interest and is now fully enrolled.
CNN Money